Climb Bio Inc. (CLYM) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Climb Bio Inc.

    NASDAQ: CLYM · Real-Time Price · USD
    2.13
    0.03 (1.43%)
    At close: Sep 26, 2025, 3:59 PM
    2.15
    0.94%
    After-hours: Sep 26, 2025, 05:47 PM EDT

    Climb Bio Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -73.9M -35.12M -45.24M -47.48M
    Depreciation & Amortization
    		 n/a n/a n/a n/a
    Stock-Based Compensation
    		 5.56M 12.81M 6.99M 3.74M
    Other Working Capital
    		 2.84M 4.45M 863K -4.49M
    Other Non-Cash Items
    		 51.08M -2.05M 674K 11.84M
    Deferred Income Tax
    		 n/a n/a n/a n/a
    Change in Working Capital
    		 1.7M 3.76M 210K -4.17M
    Operating Cash Flow
    		 -15.56M -20.6M -37.37M -36.07M
    Capital Expenditures
    		 n/a n/a n/a n/a
    Cash Acquisitions
    		 n/a n/a n/a n/a
    Purchase of Investments
    		 -132.2M -58.45M -87.96M -114.97M
    Sales Maturities Of Investments
    		 20.75M 127.43M 122.4M n/a
    Other Investing Acitivies
    		 -9.64M n/a n/a n/a
    Investing Cash Flow
    		 -121.09M 68.98M 34.44M -114.97M
    Debt Repayment
    		 n/a n/a n/a n/a
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 10.98M n/a n/a 149K
    Financial Cash Flow
    		 130.73M 841K n/a 177.23M
    Net Cash Flow
    		 -5.88M 49.53M -3.34M 26.43M
    Free Cash Flow
    		 -15.56M -20.6M -37.37M -36.07M

    Add to Watchlist